Biotech
PLEASANTON, CA: PLEASANTON, CA -- (Marketwire) -- 01/09/12 -- IntegenX Inc., the leading developer of rapid human DNA identification technology, DNA sequencing library preparation systems, and DNA/RNA room temperatu ...
BRIDGEWATER, NJ: BRIDGEWATER, NJ -- (Marketwire) -- 01/09/12 -- Aptalis Pharma, a global specialty pharmaceutical company focused on gastrointestinal diseases and cystic fibrosis, today announced that it has signed ...
MONTREAL, QUEBEC and LES ULIS, FRANCE: MONTREAL, QUEBEC and LES ULIS, FRANCE -- (Marketwire) -- 01/09/12 -- Thallion Pharmaceuticals Inc. (TSX: TLN) and LFB Biotechnologies announced today that they have completed patient enrollment for ...
SAN FRANCISCO, CA and TOKYO: SAN FRANCISCO, CA and TOKYO -- (Marketwire) -- 01/09/12 -- Medivation, Inc. (NASDAQ: MDVN) and Astellas Pharma Inc. today announced that data from the Phase 3 AFFIRM trial, evaluating MDV3100 in men ...
AURORA, ON: AURORA, ON -- (Marketwire) -- 01/09/12 -- Helix BioPharma Corp. (TSX: HBP) (NYSE Amex: HBP) (FRANKFURT: HBP) (the "Company" or "Helix") announces that Mr. Jack M. Kay has been ap ...
BOTHELL, WA: Financing Provides Flexibility to Execute on Pre-Clinical, Clinical and Partnering Objectives ...
BALTIMORE, MD: Company to Present Overview and Update on Development Milestones ...
WASHINGTON, DC: Speakers Include Advanced Cell Technology, Athersys, Cytori, Dendreon, Genzyme-Sanofi, Johnson & Johnson, Mesoblast, and Shire ...
HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwire) -- 01/05/12 -- Immunovaccine Inc. (TSX VENTURE: IMV), a clinical stage vaccine developer, will present at Biotech Showcase in conjunction with attending the J.P. ...
LEIDEN, THE NETHERLANDS: LEIDEN, THE NETHERLANDS -- (Marketwire) -- 01/05/12 -- OctoPlus N.V. ("OctoPlus" or the "Company") (EURONEXT: OCTO) announces today that it has won an expansion of its drug deliv ...
IRVINE, CA: Expects Profitability in 2011 for the Second Consecutive Year on an Adjusted Cash Net Income Basis Unaudited 2011 Net Revenues Expected to Be Greater Than $160 Million 2012 Net Revenues Expected to Gr ...
IRVINE, CA: IRVINE, CA -- (Marketwire) -- 01/04/12 -- ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA) today announced it has initiated a Phase 2 clinical study of its BEPOSONE™ nasal spray combining bepotastine bes ...
MELBOURNE, AUSTRALIA: Huntington Study Group Appointed to Coordinate the Trial and Start Recruitment ...
HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwire) -- 01/04/12 -- Immunovaccine Inc. (TSX VENTURE: IMV) today announced the first patient has been vaccinated with DPX-Survivac, a therapeutic cancer vaccine. The g ...
BOTHELL, WA: BOTHELL, WA -- (Marketwire) -- 01/04/12 -- AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based therapeutics, announced today that the independent Data Safety Monitoring Board (DSMB) providi ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwire) -- 01/04/12 -- MethylGene Inc. (TSX: MYG) today announced the appointment of Rachel Humphrey, MD, to the post of Executive Vice President and Chief Medical Officer. ...
OSLO, NORWAY: OSLO, NORWAY -- (Marketwire) -- 01/04/12 --Bionor Pharma ASA (OSLO: BIONOR), Eurocine Vaccines AB and Oslo University Hospital today announced that the nasal immunization study combining Bionor Pharma ...
CARDIFF, CA: CARDIFF, CA -- (Marketwire) -- 01/04/12 -- NeuroPerspective has released its January issue, which reviews 2011 and previews 2012 for the CNS therapeutics sector.The review of 2011 includes NeuroPersp ...
PERTH, AUSTRALIA: PERTH, AUSTRALIA -- (Marketwire) -- 01/04/12 -- Phylogica Ltd (ASX: PYC) (XETRA: PH7), a leading Australian peptide drug discovery company, announced today a Collaboration and Option agreement with J ...
BRISBANE, AUSTRALIA: BRISBANE, AUSTRALIA -- (Marketwire) -- 01/04/12 -- (ASX: ACL) -- Alchemia Limited is pleased to announce that the first patient in the pivotal Phase III clinical study of its lead cancer drug, HA-Ir ...
